Silicosis and Pulmonary Sarcoidosis: A Crossroads of Interstitial Lung Diseases

Interstitial lung diseases (ILDs) comprise a heterogeneous spectrum of conditions characterized by inflammation or fibrosis of the pulmonary parenchyma. In this context, silicosis and pulmonary sarcoidosis, traditionally considered separate entities due to their etiology, share more common ground than historically recognized. Growing evidence on the systemic effects of respirable crystalline silica has sparked interest in exploring potential pathophysiological intersections between these two diseases.